Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Characterization and prognosis of patients with hepatocellular carcinoma (HCC) in the non-cirrhotic liver
Kerstin Schütte, Christian Schulz, Janine Poranzke, et al.
BMC Gastroenterology (2014) Vol. 14, Iss. 1
Open Access | Times Cited: 125

Showing 1-25 of 125 citing articles:

Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review
Aakash Desai, Sonia Sandhu, Jinping Lai, et al.
World Journal of Hepatology (2019) Vol. 11, Iss. 1, pp. 1-18
Open Access | Times Cited: 281
Systematic review with meta‐analysis: risk of hepatocellular carcinoma in non‐alcoholic steatohepatitis without cirrhosis compared to other liver diseases
Jonathan G. Stine, Brian J. Wentworth, Alex Zimmet, et al.
Alimentary Pharmacology & Therapeutics (2018) Vol. 48, Iss. 7, pp. 696-703
Open Access | Times Cited: 278
The story of HCC in NAFLD: from epidemiology, across pathogenesis, to prevention and treatment
Cristina Margini, Jean‐François Dufour
Liver International (2015) Vol. 36, Iss. 3, pp. 317-324
Open Access | Times Cited: 228
Current epidemiology in hepatocellular carcinoma
Peter Konyn, Aijaz Ahmed, Donghee Kim
Expert Review of Gastroenterology & Hepatology (2021) Vol. 15, Iss. 11, pp. 1295-1307
Closed Access | Times Cited: 202
Nonalcoholic Fatty Liver Disease in Adults: Current Concepts in Etiology, Outcomes, and Management
Thomas Marjot, Ahmad Moolla, Jeremy Cobbold, et al.
Endocrine Reviews (2019) Vol. 41, Iss. 1, pp. 66-117
Open Access | Times Cited: 194
Incidence of Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-analysis, and Meta-regression
Lorenzo A. Orci, Marco Sanduzzi‐Zamparelli, Berta Caballol, et al.
Clinical Gastroenterology and Hepatology (2021) Vol. 20, Iss. 2, pp. 283-292.e10
Open Access | Times Cited: 162
Deep Learning-Based Classification of Hepatocellular Nodular Lesions on Whole-Slide Histopathologic Images
Na Cheng, Yong Ren, Jing Zhou, et al.
Gastroenterology (2022) Vol. 162, Iss. 7, pp. 1948-1961.e7
Open Access | Times Cited: 71
Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis
Bashar Mohamad, Vaishal Shah, Mykola Onyshchenko, et al.
Hepatology International (2015) Vol. 10, Iss. 4, pp. 632-639
Closed Access | Times Cited: 147
Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance
Per Stål
World Journal of Gastroenterology (2015) Vol. 21, Iss. 39, pp. 11077-11077
Open Access | Times Cited: 143
Role of liver biopsy in hepatocellular carcinoma
Luca Di Tommaso, Marco Spadaccini, Matteo Donadon, et al.
World Journal of Gastroenterology (2019) Vol. 25, Iss. 40, pp. 6041-6052
Open Access | Times Cited: 125
Diagnosis and treatment of hepatocellular carcinoma: An update
Javier Tejeda-Maldonado
World Journal of Hepatology (2015) Vol. 7, Iss. 3, pp. 362-362
Open Access | Times Cited: 120
Characteristics, aetiologies and trends of hepatocellular carcinoma in patients without cirrhosis: a United States multicentre study
Samer Gawrieh, Lara Dakhoul, Ethan Miller, et al.
Alimentary Pharmacology & Therapeutics (2019) Vol. 50, Iss. 7, pp. 809-821
Open Access | Times Cited: 99
 Economic growth leads to increase of obesity and associated hepatocellular carcinoma in developing countries.
Gönül Şeyda SEYDEL, Özlem Kücükoglu, Akif Altinbasv, et al.
DOAJ (DOAJ: Directory of Open Access Journals) (2016) Vol. 15, Iss. 5, pp. 662-72
Closed Access | Times Cited: 86
The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment
Patrizia Leone, Antonio Giovanni Solimando, Rossella Fasano, et al.
Vaccines (2021) Vol. 9, Iss. 5, pp. 532-532
Open Access | Times Cited: 80
Non-alcoholic fatty liver disease and hepatocellular carcinoma: Clinical challenges of an intriguing link
Lampros Chrysavgis, Ilias Giannakodimos, Panagiota Diamantopoulou, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 3, pp. 310-331
Open Access | Times Cited: 57
Alcohol-associated liver cancer
Yaojie Fu, Luca Maccioni, Xin Wei Wang, et al.
Hepatology (2024) Vol. 80, Iss. 6, pp. 1462-1479
Closed Access | Times Cited: 11
Epidemiology of non-alcoholic fatty liver disease-related hepatocellular carcinoma and its implications
Sui‐Weng Wong, Yi‐Wen Ting, Wah‐Kheong Chan
JGH Open (2018) Vol. 2, Iss. 5, pp. 235-241
Open Access | Times Cited: 65
Liver cancer: A leading cause of cancer death in the United States and the role of the 1945–1965 birth cohort by ethnicity
Paulo S. Pinheiro, Karen E. Callahan, Patricia D. Jones, et al.
JHEP Reports (2019) Vol. 1, Iss. 3, pp. 162-169
Open Access | Times Cited: 60
Unique situation of hepatocellular carcinoma in Egypt: A review of epidemiology and control measures
Reem Ezzat, Mohamed Eltabbakh, Mohamed El‐Kassas
World Journal of Gastrointestinal Oncology (2021) Vol. 13, Iss. 12, pp. 1919-1938
Open Access | Times Cited: 49
Hepcidin in hepatocellular carcinoma
Jonathan H. Joachim, Kosha J. Mehta
British Journal of Cancer (2022) Vol. 127, Iss. 2, pp. 185-192
Open Access | Times Cited: 34
Cryptogenic non-cirrhotic HCC: Clinical, prognostic and immunologic aspects of an emerging HCC etiology
Boris J. B. Beudeker, Rael Guha, Kalina Stoyanova, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers
Suzanne van Meer, Karel J. van Erpecum, Dave Sprengers, et al.
European Journal of Gastroenterology & Hepatology (2015) Vol. 28, Iss. 3, pp. 352-359
Open Access | Times Cited: 61
Racial/ethnic disparities in hepatocellular carcinoma treatment and survival in California, 1988-2012
Susan L. Stewart, Sandy Kwong, Christopher L. Bowlus, et al.
World Journal of Gastroenterology (2016) Vol. 22, Iss. 38, pp. 8584-8584
Open Access | Times Cited: 59
Hepatocellular carcinoma in Gaucher disease: an international case series
Martine Regenboog, Laura van Dussen, Joanne Verheij, et al.
Journal of Inherited Metabolic Disease (2018) Vol. 41, Iss. 5, pp. 819-827
Open Access | Times Cited: 50
MicroRNA-15b in extracellular vesicles from arsenite-treated macrophages promotes the progression of hepatocellular carcinomas by blocking the LATS1-mediated Hippo pathway
Junjie Li, Junchao Xue, Ling Min, et al.
Cancer Letters (2020) Vol. 497, pp. 137-153
Closed Access | Times Cited: 42
Page 1 - Next Page

Scroll to top